REWARDS Premier Taxus-Liberte vs Xience V
| Status: | Completed |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/15/2016 |
| Start Date: | September 2014 |
| End Date: | October 2015 |
REWARDS-Premier TLX (Registry Experience at the WAshington Hospital CenteR, DeS - Premier Taxus-Liberte vs Xience V)
Multicenter, retrospective registry to collect baseline, clinical, procedural, in hospital
and 9-12 month follow-up data to compare major adverse cardiac events in patients receiving
Promus Premier drug eluting stent to data already collected from the REWARDS-TLX Registry in
which patients received either the Taxus Liberte or XIENCE V drug eluting stent.
and 9-12 month follow-up data to compare major adverse cardiac events in patients receiving
Promus Premier drug eluting stent to data already collected from the REWARDS-TLX Registry in
which patients received either the Taxus Liberte or XIENCE V drug eluting stent.
Inclusion Criteria:
- Patients 18 years of age or older
- Underwent PCI with Promus Premier (alone) DES
Exclusion Criteria:
- Underwent PCI with a non-Promus Premier DES during the same index procedure
- Patients not taking, or unable to take, dual antiplatelet therapy (aspirin plus
clopidogrel, prasugrel, or ticagrelor)
We found this trial at
1
site
110 Irving St NW
Washington, District of Columbia 20010
Washington, District of Columbia 20010
(202) 877-7000
Washington Hosp Ctr MedStar Washington Hospital Center is a not-for-profit, 926-bed, major teaching and research...
Click here to add this to my saved trials
